PACB
Pacific Biosciences of California
2.70$
-5.9%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -10.6% | +202.4% | -28.6% | -40.6% | +5.0% | -8.6% | +5.3% | +5.2% | +4.5% | +18.2% | -13.1% | +179.7% | +384.8% | -12.0% | -1.2% | -27.8% | -37.8% | |
| – | – | -12.3% | +212.7% | -31.9% | -42.4% | +10.0% | -6.9% | -6.1% | -1.4% | -6.8% | +29.6% | -38.4% | +338.7% | +209.7% | -22.6% | -12.9% | -33.2% | -24.3% | |
| – | – | +13.7% | +65.5% | -60.1% | -20.9% | -43.4% | +38.3% | +125.7% | -79.6% | +275.0% | -70.0% | +57.2% | +175.5% | +464.5% | -29.4% | -44.7% | -69.2% | +15.1% | |
| – | – | -12.6% | +205.9% | -37.5% | -43.3% | +11.9% | -9.9% | -18.8% | -12.5% | -12.7% | +62.8% | -52.0% | +549.3% | +227.6% | -26.1% | -18.2% | -38.2% | -28.3% | |
| – | – | – | – | +1,236.4% | -38.1% | -2.7% | +24.0% | +54.0% | +117.8% | +17.6% | -36.0% | +77.6% | +10.3% | +44.0% | -22.5% | +94.9% | -24.8% | +28.8% | |
| – | – | – | – | +126.1% | -38.2% | +4.8% | +12.8% | -3.4% | +42.7% | +47.5% | -22.5% | -25.5% | +6.9% | +72.9% | +104.8% | +12.5% | +3.7% | -16.1% | |
| – | – | +18.5% | +72.4% | +49.4% | -22.1% | -35.5% | -28.5% | +29.5% | +70.3% | +160.4% | -10.1% | -11.7% | -17.2% | +217.8% | +2.8% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | +12.8% | -31.3% | +0.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -0.2% | +11.4% | -14.8% | -96.1% | |
| – | – | +34.7% | -90.7% | +3.8% | -24.4% | +230.1% | +3.8% | -17.3% | -7.6% | +9.0% | -3.0% | +65.6% | -15.7% | +1,449.2% | -1.0% | -13.2% | -27.8% | +3.3% | |
| – | – | +79.1% | +147.5% | -7.0% | -23.9% | +53.0% | +39.6% | -30.4% | +54.0% | -33.9% | -8.8% | +141.6% | -21.7% | +86.2% | +267.2% | -63.9% | -30.2% | -17.9% | |
| – | – | – | – | -36.4% | +23.6% | +21.4% | +5,348.1% | -81.8% | +696.0% | -62.1% | -0.2% | +213.5% | -78.0% | +115.1% | +15.1% | -6.0% | -0.5% | -95.5% | |
| – | – | +213.2% | +64.7% | -50.2% | -37.0% | -42.5% | +226.6% | -15.3% | +76.0% | +8.8% | -25.9% | +24.2% | -57.2% | +207.4% | +9.3% | +25.2% | +10.1% | +25.2% | |
| – | – | – | – | -4.8% | -6.2% | +410.8% | +5.8% | +5.8% | +7.7% | -15.3% | +7.5% | +8.3% | – | – | +0.1% | -0.5% | -27.4% | -0.3% | |
| – | – | – | – | -31.6% | -42.9% | -36.8% | -20.6% | +33.8% | +15.1% | +1.7% | +32.5% | -51.9% | +510.9% | +135.8% | -28.8% | +24.6% | -27.8% | -98.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +3,375.0% | +100.3% | +3.5% | +12.7% | +12.2% | +7.3% | +17.9% | +18.5% | +27.8% | +12.9% | +14.7% | +16.7% | +10.0% | +12.9% | +13.7% | +4.0% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.